Search Results - "Wood, Matthew J."
-
1
Advances in oligonucleotide drug delivery
Published in Nature reviews. Drug discovery (01-10-2020)“…Oligonucleotides can be used to modulate gene expression via a range of processes including RNAi, target degradation by RNase H-mediated cleavage, splicing…”
Get full text
Journal Article -
2
DNA Cage Delivery to Mammalian Cells
Published in ACS nano (26-07-2011)“…DNA cages are nanometer-scale polyhedral structures formed by self-assembly from synthetic DNA oligonucleotides. Potential applications include in vivo imaging…”
Get full text
Journal Article -
3
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Published in Nature biotechnology (01-04-2011)“…To realize the therapeutic potential of RNA drugs, efficient, tissue-specific and nonimmunogenic delivery technologies must be developed. Here we show that…”
Get full text
Journal Article -
4
An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
Published in Current opinion in pharmacology (01-10-2015)“…Highlights • Recent human clinical trial data on RNAi approaches to gene down-regulation for genetic diseases. • Overview of current anti-microRNA drugs with…”
Get full text
Journal Article -
5
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Published in Experimental & molecular medicine (01-03-2019)“…Extracellular vesicles (EVs) are increasingly being recognized as mediators of intercellular signaling via the delivery of effector molecules. Interestingly,…”
Get full text
Journal Article -
6
Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods
Published in PloS one (21-12-2015)“…Exosomes are emerging targets for biomedical research. However, suitable methods for the isolation of blood plasma-derived exosomes without impurities have not…”
Get full text
Journal Article -
7
Therapeutic approaches for Duchenne muscular dystrophy
Published in Nature reviews. Drug discovery (01-11-2023)“…Duchenne muscular dystrophy (DMD) is a monogenic muscle-wasting disorder and a priority candidate for molecular and cellular therapeutics. Although rare, it is…”
Get full text
Journal Article -
8
The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease
Published in Philosophical transactions of the Royal Society of London. Series B. Biological sciences (26-09-2014)“…Long non-coding RNAs (lncRNAs) are transcripts with low protein-coding potential that represent a large proportion of the transcriptional output of the cell…”
Get full text
Journal Article -
9
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Published in The Lancet (British edition) (13-08-2011)“…Summary Background We report clinical safety and biochemical efficacy from a dose-ranging study of intravenously administered AVI-4658 phosphorodiamidate…”
Get full text
Journal Article -
10
The Genesis of Pain in Osteoarthritis: Inflammation as a Mediator of Osteoarthritis Pain
Published in Clinics in geriatric medicine (01-05-2022)“…Chronic pain is a substantial personal and societal burden worldwide. Osteoarthritis (OA) is one of the leading causes of chronic pain and is increasing in…”
Get full text
Journal Article -
11
Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression
Published in Frontiers in immunology (30-04-2018)“…Cells release membrane enclosed nano-sized vesicles termed extracellular vesicles (EVs) that function as mediators of intercellular communication by…”
Get full text
Journal Article -
12
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Published in Journal of extracellular vesicles (01-01-2015)“…Extracellular vesicles (EVs) have emerged as important mediators of intercellular communication in a diverse range of biological processes. For future…”
Get full text
Journal Article -
13
Targeting RNA to treat neuromuscular disease
Published in Nature reviews. Drug discovery (01-08-2011)“…Key Points Neuromuscular disorders comprise a heterogeneous group of clinical conditions that primarily affect one or more components of the neuromuscular unit…”
Get full text
Journal Article -
14
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Published in Nature reviews. Neurology (01-01-2018)“…Key Points Antisense oligonucleotides (ASOs) are short, synthetic, single-stranded oligodeoxynucleotides that can alter RNA and reduce, restore, or modify…”
Get full text
Journal Article -
15
A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA
Published in Nature communications (28-02-2020)“…Extracellular vesicles (EVs) form an endogenous transport system for intercellular transfer of biological cargo, including RNA, that plays a pivotal role in…”
Get full text
Journal Article -
16
Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER
Published in The Journal of cell biology (25-04-2016)“…Exosomes are nanovesicles released by virtually all cells, which act as intercellular messengers by transfer of protein, lipid, and RNA cargo. Their…”
Get full text
Journal Article -
17
Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons
Published in Human molecular genetics (15-11-2017)“…The recent generation of induced pluripotent stem cells (iPSCs) from a patient with Parkinson's disease (PD) resulting from triplication of the α-synuclein…”
Get full text
Journal Article -
18
Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum
Published in PloS one (19-02-2014)“…Extracellular microRNAs (miRNAs) are under investigation as minimally-invasive biomarkers for a wide range of disease conditions. We have recently shown in a…”
Get full text
Journal Article -
19
The viral protein corona directs viral pathogenesis and amyloid aggregation
Published in Nature communications (27-05-2019)“…Artificial nanoparticles accumulate a protein corona layer in biological fluids, which significantly influences their bioactivity. As nanosized obligate…”
Get full text
Journal Article -
20
Genetic therapies for RNA mis-splicing diseases
Published in Trends in genetics (01-05-2011)“…RNA mis-splicing diseases account for up to 15% of all inherited diseases, ranging from neurological to myogenic and metabolic disorders. With greatly…”
Get full text
Journal Article